{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:29:52Z","timestamp":1791815392336,"version":"4.3.4"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Soluble markers of B cell activation are interesting diagnostic and prognostic tools in autoimmune diseases. Data in systemic sclerosis (SSc) are scarce and few studies focused on their association with disease characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>1. Serum levels of 14 B cell biomarkers (\u03b22-microglobulin, rheumatoid factor (RF), immunoglobulins (Ig) G, IgA, IgM, BAFF, APRIL, soluble (s)TACI, sBCMA sCD21, sCD23, sCD25, sCD27, CXCL13) were measured in SSc patients and healthy controls (HC). 2. Associations between these biomarkers and SSc characteristics were assessed. 3. The pathophysiological relevance of identified associations was explored by studying protein production in B cell culture supernatant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In a discovery panel of 80 SSc patients encompassing the broad spectrum of disease manifestations, we observed a higher frequency of RF positivity, and increased levels of \u03b22-microglobulin, IgG and CXCL13 compared with HC. We found significant associations between several biomarkers and SSc characteristics related to disease phenotype, activity and severity. Especially, serum IgG levels were associated with pulmonary hypertension (PH); \u03b22-microglobulin with Nt-pro-BNP and DLCO; and BAFF with peak tricuspid regurgitation velocity (TRV). In a validation cohort of limited cutaneous SSc patients without extensive ILD, we observed lower serum IgG levels, and higher \u03b22-microglobulin, sBCMA, sCD23 and sCD27 levels in patients with pulmonary arterial hypertension (PAH). BAFF levels strongly correlated with Nt-pro-BNP levels, FVC\/DLCO ratio and peak TRV in SSc-PAH patients. Cultured SSc B cells showed increased production of various angiogenic factors (angiogenin, angiopoietin-1, VEGFR-1, PDGF-AA, MMP-8, TIMP-1, L-selectin) and decreased production of angiopoietin-2 compared to HC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Soluble markers of B cell activation could be relevant tools to assess organ involvements, activity and severity in SSc. Their associations with PAH could plead for a role of B cell activation in the pathogenesis of pulmonary microangiopathy. B cells may contribute to SSc vasculopathy through production of angiogenic mediators.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.954007","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:05:05Z","timestamp":1659110705000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension"],"prefix":"10.3389","volume":"13","author":[{"given":"S\u00e9bastien","family":"Sanges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Guerrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Duhamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Hauspie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Largy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eft\u00e9","family":"Balden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Podevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Jendoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Speca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sobanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Dubucquoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1867-1","article-title":"Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","article-title":"Diagnosis and classification of systemic sclerosis","volume":"40","author":"Hachulla","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2011.02.004","article-title":"[Complaints, needs of patients with systemic sclerosis: a better understanding for a better care]","volume":"32","author":"Morell-Dubois","year":"2011","journal-title":"Rev M\u00e9decine Interne"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: A systematic review and meta-analysis: Survival and prognosis in SSc-associated pulmonary hypertension","volume":"65","author":"Lef\u00e8vre","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2473","article-title":"Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease","volume":"140","author":"Launay","year":"2011","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2014.08.001","article-title":"Pathophysiology of systemic sclerosis: State of the art in 2014","volume":"43","author":"Dumoitier","year":"2014","journal-title":"Presse M\u00e9dicale"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2016.02.016","article-title":"Role of b cells in the pathogenesis of systemic sclerosis","volume":"38","author":"Sanges","year":"2017","journal-title":"Rev M\u00e9decine Interne"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0505-4","article-title":"Functional autoantibodies in systemic sclerosis pathogenesis","volume":"17","author":"Kill","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00053","article-title":"B cell homeostasis and functional properties are altered in an hypochlorous acid-induced murine model of systemic sclerosis","volume":"8","author":"Sanges","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.10.015","article-title":"Altered b lymphocyte homeostasis and functions in systemic sclerosis","volume":"17","author":"Forestier","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2021.11.009","article-title":"Biomarkers of b cell activation in autoimmune connective tissue diseases: More than markers of disease activity","volume":"100","author":"Du","year":"2022","journal-title":"Clin Biochem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315608254","article-title":"Association of BAFF, APRIL serum levels, BAFF-r, TACI and BCMA expression on peripheral b-cell subsets with clinical manifestations in systemic lupus erythematosus","volume":"25","author":"Salazar-Camarena","year":"2016","journal-title":"Lupus"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/ncomms8333","article-title":"\u03b3-secretase directly sheds the survival receptor BCMA from plasma cells","volume":"6","author":"Laurent","year":"2015","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402070","article-title":"The immunoregulator soluble TACI is released by ADAM10 and reflects b cell activation in autoimmunity","volume":"194","author":"Hoffmann","year":"2015","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.12.012","article-title":"Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices","volume":"135","author":"Hegazy","year":"2010","journal-title":"Clin Immunol Orlando Fla"},{"key":"B16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/ard.2008.090928","article-title":"Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and b lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus","volume":"68","author":"Morel","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.022491","article-title":"Raised serum APRIL levels in patients with systemic lupus erythematosus","volume":"64","author":"Koyama","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"R252","DOI":"10.1186\/ar4095","article-title":"APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis","volume":"14","author":"Treamtrakanpon","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0037","article-title":"B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS\u2013associated non-Hodgkin b-cell lymphoma","volume":"20","author":"Breen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1639","article-title":"Markers of b-cell activation in relation to risk of non-Hodgkin lymphoma","volume":"72","author":"De Roos","year":"2012","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201981","article-title":"Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis","volume":"72","author":"Monach","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13075-016-0978-1","article-title":"Regulatory and effector b cell cytokine production in patients with relapsing granulomatosis with polyangiitis","volume":"18","author":"Land","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary sj\u00f6gren\u2019s syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1186\/ar4552","article-title":"Serum c-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels","volume":"16","author":"Jones","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B25","first-page":"23","article-title":"B-cell-attracting chemokine-1 (BCA-1\/CXCL13) in systemic lupus erythematosus, its correlation to disease activity and renal involvement","volume":"21","author":"Hafez","year":"2014","journal-title":"Egypt J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0434-z","article-title":"CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic \u201cwindow of opportunity","volume":"16","author":"Greisen","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.07.003","article-title":"Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity","volume":"13","author":"Lanteri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jbspin.2010.05.004","article-title":"Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis","volume":"78","author":"Bassyouni","year":"2011","journal-title":"Joint Bone Spine"},{"key":"B29","article-title":"Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF","volume":"34","author":"Matsushita","year":"2007","journal-title":"J Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/BF02031609","article-title":"Serum beta 2-microglobulin in systemic sclerosis","volume":"4","author":"Pagano","year":"1985","journal-title":"Clin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.070","article-title":"Efficacy of BAFF in monitoring treatment response in early Vietnamese systemic sclerosis patients","volume":"7","author":"Minh","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2017-204656","article-title":"Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu","volume":"71","author":"Bosello","year":"2018","journal-title":"J Clin Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12411","article-title":"CXCL13 and b-cell activating factor as putative biomarkers in systemic sclerosis","volume":"169","author":"Wutte","year":"2013","journal-title":"Br J Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.12019","article-title":"Serum b-cell activating factor assessment in a population of Egyptian patients with systemic sclerosis","volume":"16","author":"Abdo","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejr.2010.12.001","article-title":"Serum BAFF level and its correlations with various disease parameters in patients with systemic sclerosis and systemic lupus erythematosus","volume":"33","author":"Fawzy","year":"2011","journal-title":"Egypt Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: Enhanced BAFF signaling in systemic sclerosis b lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13724","article-title":"CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis","volume":"27","author":"Taniguchi","year":"2018","journal-title":"Exp Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000387","article-title":"Serum IgG subclasses in autoimmune diseases","volume":"94","author":"Zhang","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/69921","article-title":"Anti-CCP antibodies and rheumatoid factor in systemic sclerosis:Prevalence and relationships with joint manifestations","volume":"27","author":"Wielosz","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbr.2014.12.011","article-title":"Sobreposi\u00e7\u00e3o de esclerose sist\u00eamica e artrite reumatoide: uma entidade cl\u00ednica distinta","volume":"56","author":"Horimoto","year":"2016","journal-title":"Rev Bras Reumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes041","article-title":"Articular involvement in systemic sclerosis","volume":"51","author":"Avouac","year":"2012","journal-title":"Rheumatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2205-3","article-title":"Evaluating hand in systemic sclerosis","volume":"32","author":"Arslan Tas","year":"2012","journal-title":"Rheumatol Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq205","article-title":"Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis","volume":"49","author":"Ueda-Hayakawa","year":"2010","journal-title":"Rheumatology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0313-3","article-title":"Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis","volume":"26","author":"Ingegnoli","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-7-260","article-title":"Erosive arthropathy in systemic sclerosis","volume":"7","author":"Allali","year":"2007","journal-title":"BMC Public Health"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1610-3","article-title":"Serum levels of soluble CD21 in patients with systemic sclerosis","volume":"32","author":"Tomita","year":"2012","journal-title":"Rheumatol Int"},{"key":"B47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1006\/immu.1994.1008","article-title":"Soluble fc epsilon RII\/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble fc epsilon RII\/CD23","volume":"4","author":"Yoshikawa","year":"1994","journal-title":"ImmunoMethods"},{"key":"B48","doi-asserted-by":"publisher","first-page":"9468","DOI":"10.1038\/s41598-019-45990-7","article-title":"Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis","volume":"9","author":"Bocchino","year":"2019","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"R188","DOI":"10.1186\/ar4019","article-title":"Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement","volume":"14","author":"Valentini","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1361.082","article-title":"Clinical correlations of potential activity markers in systemic sclerosis","volume":"1051","author":"Be\u010dv\u00e1\u0159","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B51","article-title":"Duration of raynaud\u2019s phenomenon is negatively correlated with serum levels of interleukin 10 (IL-10), soluble receptor of interleukin 2 (sIL2R), and sFas in systemic sclerosis patients","volume":"10","author":"Dziankowska-Bartkowiak","year":"2004","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"B52","article-title":"[Soluble receptors of cytokines in sera of patients with systemic sclerosis\u2013clinical correlation]","volume":"56","author":"Lis","year":"2003","journal-title":"Wiadomosci Lek Wars Pol 1960"},{"key":"B53","first-page":"69","article-title":"Type III procollagen n-terminal propeptide, soluble interleukin-2 receptor, and von willebrand factor in systemic sclerosis","volume":"19","author":"Lee","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"B54","article-title":"Treatment of raynaud\u2019s phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis","volume":"28","author":"Gardinali","year":"2001","journal-title":"J Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.3.304","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin","volume":"37","author":"S\u00f8ndergaard","year":"1998","journal-title":"Br J Rheumatol"},{"key":"B56","article-title":"Soluble serum interleukin 2 receptors in patients with systemic sclerosis","volume":"23","author":"Steen","year":"1996","journal-title":"J Rheumatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 lassification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B58","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.6.592","article-title":"European Multicentre study to define disease activity criteria for systemic sclerosis. II. identification of disease activity variables and development of preliminary activity indexes","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"B62","article-title":"Assessment of disease severity and prognosis in systemic sclerosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10067-004-0942-3","article-title":"Validation of French version of the scleroderma health assessment questionnaire (SSc HAQ)","volume":"24","author":"Georges","year":"2005","journal-title":"Clin Rheumatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1177\/001316447303300111","article-title":"Eta-squared and partial eta-squared in fixed factor anova designs","volume":"33","author":"Cohen","year":"1973","journal-title":"Educ Psychol Meas"},{"key":"B65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semarthrit.2020.10.009","article-title":"Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments","volume":"51","author":"Scherlinger","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2018.72662","article-title":"Overlap syndromes in systemic sclerosis","volume":"35","author":"Wielosz","year":"2018","journal-title":"Adv Dermatol Allergol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204487","article-title":"Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis","volume":"74","author":"Moinzadeh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B68","first-page":"14","article-title":"Scleroderma overlap syndrome","volume-title":"Isr Med Assoc J","author":"Balbir-Gurman","year":"2011"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.4.230","article-title":"Assessment of anti-endothelial cell antibodies in systemic sclerosis and sj\u00f6gren\u2019s syndrome","volume":"56","author":"Hebbar","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"B70","article-title":"Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension","volume":"25","author":"Negi","year":"1998","journal-title":"J Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.6.2.156-160.1999","article-title":"Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment","volume":"16","author":"Pignone","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01115.x","article-title":"Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis","volume":"119","author":"Ihn","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1309\/8HVCMJMYNPUQPBD2","article-title":"The assessment of anti\u2013endothelial cell antibodies in scleroderma-associated pulmonary fibrosis","volume":"120","author":"Wusirika","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.029082","article-title":"Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension","volume":"60","author":"Tamby","year":"2005","journal-title":"Thorax"},{"key":"B75","article-title":"More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. are they useful tools for prognostic use in systemic sclerosis","volume":"26","author":"Riccieri","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type a on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"G\u00fcnther","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B79","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150061","article-title":"Autoantibodies against endothelin 1 type a receptor are strong predictors of digital ulcers in systemic sclerosis","volume":"42","author":"Avouac","year":"2015","journal-title":"J Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3892\/ijmm.21.2.233","article-title":"Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency","volume":"21","author":"Jin","year":"2008","journal-title":"Int J Mol Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e000063","DOI":"10.1136\/lupus-2014-000063","article-title":"BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year","volume":"2","author":"Zollars","year":"2015","journal-title":"Lupus Sci Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12931-021-01716-w","article-title":"Plasma markers in pulmonary hypertension subgroups correlate with patient survival","volume":"22","author":"Koudstaal","year":"2021","journal-title":"Respir Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12931-016-0336-5","article-title":"CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"17","author":"Olsson","year":"2016","journal-title":"Respir Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","article-title":"Pulmonary arterial hypertension: a rare complication of primary sj\u00f6gren syndrome: report of 9 new cases and review of the literature","volume":"86","author":"Launay","year":"2007","journal-title":"Med (Baltimore)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13290","article-title":"Characteristics and risk factors of pulmonary arterial hypertension in patients with primary sj\u00f6gren\u2019s syndrome","volume":"21","author":"Yan","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019245","article-title":"TNFRSF13B c.226G>A (p.Gly76Ser) as a novel causative mutation for pulmonary arterial hypertension","volume":"10","author":"Shinya","year":"2021","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aan8289","article-title":"Dynamics of the human antibody repertoire after b cell depletion in systemic sclerosis","volume":"2","author":"de Bourcy","year":"2017","journal-title":"Sci Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/148293","article-title":"Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease","volume":"2014","author":"L\u00f3pez-Cacho","year":"2014","journal-title":"BioMed Res Int"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119151","article-title":"Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis","volume":"271","author":"Zhang","year":"2021","journal-title":"Life Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108364","article-title":"CD21low b cells in systemic sclerosis: A possible marker of vascular complications","volume":"213","author":"Marrapodi","year":"2020","journal-title":"Clin Immunol Orlando Fla"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202009-3481OC","article-title":"Safety and efficacy of b-cell depletion with rituximab for the treatment of systemic sclerosis associated pulmonary arterial hypertension: A multi-center, double-blind, randomized, placebo-controlled trial","author":"Zamanian","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1796","article-title":"Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in b-cell differentiation and lymphomagenesis","volume":"97","author":"Guedez","year":"2001","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.010","article-title":"Lactate induces production of the tRNAHis half to promote b-lymphoblastic cell proliferation","volume":"28","author":"Mo","year":"2020","journal-title":"Mol Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.virol.2015.02.015","article-title":"Novel expression and regulation of TIMP-1 in Epstein Barr virus-infected cells and its impact on cell survival","volume":"481","author":"Lin","year":"2015","journal-title":"Virology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2011.n.041","article-title":"Matrix metalloproteinase-8 is overexpressed in waldenstr\u00f6m\u2019s macroglobulinemia cells, and specific inhibition of this metalloproteinase blocks release of soluble CD27","volume":"11","author":"Zhou","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.06.023","article-title":"Increased angiogenesis induced by chronic lymphocytic leukemia b cells is mediated by leukemia-derived Ang2 and VEGF","volume":"34","author":"Maffei","year":"2010","journal-title":"Leuk Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02052-08","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis","volume":"83","author":"Sadagopan","year":"2009","journal-title":"J\u00a0Virol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404363","article-title":"Gene expression signatures separate b-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status","volume":"20","author":"H\u00fcttmann","year":"2006","journal-title":"Leukemia"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1385","article-title":"Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic\/plasmablastic tumors","volume":"105","author":"Guedez","year":"2005","journal-title":"Blood"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402467","article-title":"B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules","volume":"16","author":"Kay","year":"2002","journal-title":"Leukemia"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/path.854","article-title":"Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions","volume":"194","author":"Wahlgren","year":"2001","journal-title":"J Pathol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11926-011-0219-1","article-title":"Angiogenesis and vasculopathy in systemic sclerosis: Evolving concepts","volume":"14","author":"Rabquer","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5345673","article-title":"Angiogenesis dysregulation in the pathogenesis of systemic sclerosis","volume":"2017","author":"Cantatore","year":"2017","journal-title":"BioMed Res Int"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.04.019","article-title":"Angiogenic cytokines and growth factors in systemic sclerosis","volume":"10","author":"Liakouli","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2011.20610","article-title":"Angiogenin and SDF-1\u03b1 serum concentration in patients with systemic sclerosis in relation to clinical status","volume":"7","author":"Dziankowska-Bartkowiak","year":"2011","journal-title":"Arch Med Sci AMS"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq392","article-title":"Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease","volume":"50","author":"Michalska-Jakubus","year":"2011","journal-title":"Rheumatol Oxf Engl"},{"key":"B109","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1573397114666180809121005","article-title":"The role of vascular endothelial growth factor in systemic sclerosis","volume":"15","author":"Flower","year":"2019","journal-title":"Curr Rheumatol Rev"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken265","article-title":"Role of PDGF in fibrotic diseases and systemic sclerosis","volume":"47","author":"Trojanowska","year":"2008","journal-title":"Rheumatology"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"B112","article-title":"Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary raynaud\u2019s phenomenon, and in normal controls","volume":"60","author":"Young-Min","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.727451","article-title":"Distinct metalloproteinase expression and functions in systemic sclerosis and fibrosis: What we know and the potential for intervention","volume":"12","author":"Leong","year":"2021","journal-title":"Front Physiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.954007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:05:18Z","timestamp":1659110718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.954007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":113,"alternative-id":["10.3389\/fimmu.2022.954007"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.954007","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"article-number":"954007"}}